When Money Shapes Autism Care

Private equity’s rapid entry into autism therapy has reshaped the market for Applied Behavior Analysis. A JAMA Pediatrics economic evaluation documented 574 private equity owned centers across 42 states by the end of 2024, while national billing figures indicate that Medicaid payments for ABA rose from about $660 million in 2019 to roughly $2.2 billion in 2023. Federal audits by the HHS Office of Inspector General have identified substantial improper fee‑for‑service Medicaid payments, including at least $56.6 million in Indiana and $18.5 million in Wisconsin, and have flagged widespread documentation failures.

Clinical staff and parents have raised concerns that efficiency targets and consolidation can increase turnover, reduce on‑site supervision, and push billing toward larger, less‑transparent units of care. If supervision is reduced or session notes are weak, the care delivered may diverge from written goals and billed hours. Nevertheless, many clinics continue to provide individualized therapy and have established training programs; the problem highlighted by audits is variability in documentation, supervision, and billing practices rather than a single uniform failure.

Families can protect their child’s care by asking for a written plan, the names and credentials of therapists who will provide face‑to‑face treatment, how many BCBA supervision hours are scheduled, and copies of detailed session notes that match billed units. If records or bills seem inconsistent, families may contact their state Medicaid agency for review or seek help from patient advocacy groups.

Researchers who analyzed ownership patterns have said they plan to study how private equity affects outcomes such as therapy intensity, medication use, and length of treatment. Clearer evidence on clinical impact should be available in coming years.